Your cart is empty.
Männedorf, Switzerland, February 22, 2012 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold an Analyst and Media Conference to discuss the full-year 2011 financial results on Thursday, March 8, 2012 at 10:00 CET in Zurich. The results will be published on March 8, 2012 at 7:00 CET.
The conference will be audio-webcast with synchronized presentation slides. Interested parties may access the webcast via Tecan’s homepage www.tecan.com. A link to the webcast will be provided immediately prior to the event.
Interested parties can also listen to the conference by phone.
The dial-in numbers for the call are as follows:
Participants from Europe: +41 91 610 5600 or +44 203 059 58 62 (UK)
Participants from the U.S.: +1 866 291 4166
Participants should if possible dial in 15 minutes before the start of the event.
The recorded webcast will be available the same day on the website www.tecan.com together with the press release, the presentation and a preprint of the Financial Report 2011.
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals,forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2010, Tecan generated sales of CHF 371 million (USD 356 million; EUR 269 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange
(TK: TECN/Reuters: TECZn.S/ ISIN: 12100191).
For further information
Head of Corporate Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89